IGF-I plays a crucial role in cancer development; upon binding to its receptor, it activates signaling pathways including PI3K/Akt and MAPK, promoting excessive colorectal cell proliferation and thereby increasing the risk of intestinal tumors (11, 12). The gene discussed is AKT1; the disease is intestinal neoplasm.